AG
ANIK icon

Algert Global’s Anika Therapeutics ANIK Stock Holding History

Algert Global’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,080
Closed -$209K – 310
2015
Q1 		$209K Hold
5,080
– – 0.12% 270
2014
Q4 		$207K Buy
+5,080
New +$199K 0.12% 249
2014
Q1 		– Sell
-28,681
Closed -$1.09M – 316
2013
Q4 		$1.09M Buy
28,681
+5,040
+21% +$155K 0.29% 126
2013
Q3 		$565K Sell
23,641
-41,888
-64% -$940K 0.16% 190
2013
Q2 		$1.11M Buy
+65,529
New +$945K 0.34% 119

Other funds holding ANIK

TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
LCP
Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

Algert Global's ANIK Position: Q2 2015 in Review

Algert Global sold out of Anika Therapeutics (ANIK) in Q2 2015, closing a stake of 5,080 shares — an estimated $209K sold.

Algert Global first reported a position in ANIK in Q2 2013 and held it in 5 quarters. The position peaked at $1.11M in Q2 2013. 136 funds tracked by Wall St. Rank hold ANIK as of Q2 2015.

  • Algert Global reported no remaining Anika Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Algert Global sold 5,080 Anika Therapeutics shares in Q2 2015, an estimated $209K.
  • Algert Global first reported a position in Anika Therapeutics in Q2 2013 and held it in 5 quarters.
  • Algert Global's Anika Therapeutics position peaked at $1.11M in Q2 2013.
  • 136 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2015.

Based on Algert Global's 13F filing for Q2 2015, filed 24 Aug 2015.